Log in to your account:
Audentes Therapeutics (BOLD) PT Raised to $46 at Leerink Partners
January 5, 2018 7:45 AM
Leerink Partners raised its ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Analyst PT Change
Audentes Therapeutics (BOLD) PT Raised to $44 at BMO Capital on 'AT123 Phase I & II Data... Significantly De-Risk the Program'
January 4, 2018 1:04 PM